Growth Metrics

Usana Health Sciences (USNA) Non-Current Deferred Tax Liability (2016 - 2026)

Usana Health Sciences (USNA) has disclosed Non-Current Deferred Tax Liability for 16 consecutive years, with $4.9 million as the latest value for Q1 2026.

  • Quarterly Non-Current Deferred Tax Liability rose 20.11% to $4.9 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $4.9 million through Jan 2026, up 20.11% year-over-year, with the annual reading at $4.9 million for FY2026, 20.11% up from the prior year.
  • Non-Current Deferred Tax Liability for Q1 2026 was $4.9 million at Usana Health Sciences, up from $4.5 million in the prior quarter.
  • The five-year high for Non-Current Deferred Tax Liability was $35.7 million in Q1 2022, with the low at $4.1 million in Q4 2024.
  • Average Non-Current Deferred Tax Liability over 5 years is $8.6 million, with a median of $4.8 million recorded in 2022.
  • The sharpest move saw Non-Current Deferred Tax Liability soared 197.11% in 2022, then tumbled 86.01% in 2023.
  • Over 5 years, Non-Current Deferred Tax Liability stood at $32.5 million in 2022, then crashed by 86.01% to $4.6 million in 2023, then fell by 10.52% to $4.1 million in 2024, then grew by 9.67% to $4.5 million in 2025, then increased by 9.51% to $4.9 million in 2026.
  • According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods came in at $4.9 million, $4.5 million, and $4.7 million for Q1 2026, Q3 2025, and Q2 2025 respectively.